Year |
Citation |
Score |
2022 |
Mark J, Fisher DT, Kim M, Emmons T, Khan ANMN, Alqassim E, Singel K, Mistarz A, Lugade A, Zhan H, Yu H, Segal B, Lele S, Frederick P, Kozbor D, et al. Carboplatin enhances lymphocyte-endothelial interactions to promote CD8 T cell trafficking into the ovarian tumor microenvironment. Gynecologic Oncology. 168: 92-99. PMID 36410228 DOI: 10.1016/j.ygyno.2022.11.001 |
0.338 |
|
2022 |
Odunsi K, Qian F, Lugade AA, Yu H, Geller MA, Fling SP, Kaiser JC, Lacroix AM, D'Amico L, Ramchurren N, Morishima C, Disis ML, Dennis L, Danaher P, Warren S, et al. Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses. Science Translational Medicine. 14: eabg8402. PMID 35294258 DOI: 10.1126/scitranslmed.abg8402 |
0.347 |
|
2021 |
Want MY, Tsuji T, Singh PK, Thorne JL, Matsuzaki J, Karasik E, Gillard B, Cortes Gomez E, Koya RC, Lugade A, Odunsi K, Battaglia S. WHSC1/NSD2 regulates immune infiltration in prostate cancer. Journal For Immunotherapy of Cancer. 9. PMID 33589522 DOI: 10.1136/jitc-2020-001374 |
0.424 |
|
2020 |
Stenzel AE, Abrams SI, Joseph JM, Goode EL, Tario JD, Wallace PK, Kaur D, Adamson AK, Buas MF, Lugade AA, Laslavic A, Taylor SE, Orr B, Edwards RP, Elishaev E, et al. Circulating CD14 HLA-DR monocytic cells as a biomarker for epithelial ovarian cancer progression. American Journal of Reproductive Immunology (New York, N.Y. : 1989). e13343. PMID 32905653 DOI: 10.1111/Aji.13343 |
0.325 |
|
2020 |
Tsuji T, Eng KH, Matsuzaki J, Battaglia S, Szender JB, Miliotto A, Gnjatic S, Bshara W, Morrison CD, Lele S, Emerson RO, Wang J, Liu S, Robins H, Lugade AA, et al. Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer. Oncotarget. 11: 2669-2683. PMID 32676168 DOI: 10.18632/Oncotarget.27666 |
0.376 |
|
2019 |
McGray AJR, Huang RY, Battaglia S, Eppolito C, Miliotto A, Stephenson KB, Lugade AA, Webster G, Lichty BD, Seshadri M, Kozbor D, Odunsi K. Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer. Journal For Immunotherapy of Cancer. 7: 189. PMID 31315674 DOI: 10.1186/s40425-019-0641-x |
0.358 |
|
2019 |
Want MY, Konstorum A, Huang RY, Jain V, Matsueda S, Tsuji T, Lugade A, Odunsi K, Koya R, Battaglia S. Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancer. Oncoimmunology. 8: e1586042. PMID 31069153 DOI: 10.1080/2162402X.2019.1586042 |
0.379 |
|
2018 |
Want MY, Lugade AA, Battaglia S, Odunsi K. Nature of tumor rejection antigens in ovarian cancer. Immunology. PMID 29772069 DOI: 10.1111/imm.12951 |
0.428 |
|
2008 |
Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, Lord EM. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 180: 3132-9. PMID 18292536 DOI: 10.4049/Jimmunol.180.5.3132 |
0.574 |
|
2007 |
Santos K, Simon DA, Conway E, Bowers WJ, Mitra S, Foster TH, Lugade A, Lord EM, Federoff HJ, Dewhurst S, Frelinger JG. Spatial and temporal expression of herpes simplex virus type 1 amplicon-encoded genes: implications for their use as immunization vectors. Human Gene Therapy. 18: 93-105. PMID 17298238 DOI: 10.1089/Hum.2006.082 |
0.529 |
|
2006 |
Gerber SA, Rybalko VY, Bigelow CE, Lugade AA, Foster TH, Frelinger JG, Lord EM. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. The American Journal of Pathology. 169: 1739-52. PMID 17071597 DOI: 10.2353/Ajpath.2006.051222 |
0.558 |
|
2005 |
Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. Journal of Immunology (Baltimore, Md. : 1950). 174: 7516-23. PMID 15944250 DOI: 10.4049/Jimmunol.174.12.7516 |
0.596 |
|
2005 |
Gerber SA, Turner MJ, Lugade AA, Moran JP, Frelinger JG, Lord EM. Characterization of a lymph node within the mouse prostate: Detailed analysis using whole mount histology. The Prostate. 63: 105-16. PMID 15468173 DOI: 10.1002/Pros.20169 |
0.466 |
|
Show low-probability matches. |